Haematologica Journal’s Post

View organization page for Haematologica Journal, graphic

665 followers

Read here results of the IELSG38 trial conducted to investigate the effects of subcutaneous rituximab on the complete remission rate and the benefits of subcutaneous rituximab maintenance in patients with extranodal marginal zone lymphoma who received front-line treatment with chlorambucil plus rituximab. https://lnkd.in/eSyviqSX

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics